buntanetap/posiphen Clinical Trials (2026): 4 Studies for Alzheimer Disease & Deep Brain Stimulation
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
4 buntanetap/posiphen clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 4 indications (including Alzheimer Disease & Deep Brain Stimulation) and 2,134 total planned enrollment. 2 Phase 3 buntanetap/posiphen trials are listed. 1 buntanetap/posiphen clinical trial is actively recruiting at 25 U.S. sites across 19 states. Most recent activity: NCT07284784 (Nov 2029).
Where to Participate: All buntanetap/posiphen Trial Sites in the U.S. (25 sites across 19 states)
Every actively recruiting buntanetap/posiphentrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | University of Alabama at Birmingham | Birmingham35233 | NCT07284784 | Map |
| AZ | Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research | Sun City85351 | NCT07284784 | Map |
| CA | Parkinson's & Movement Disorder Institute (PMDI) - Orange County Office | Fountain Valley92708 | NCT07284784 | Map |
| CO | Cenexel Rocky Mountain Clinical Research | Englewood80113 | NCT07284784 | Map |
| CT | New England Institute for Clinical Research (Ki Health Partners) | Stamford06824 | NCT07284784 | Map |
| FL | First Choice Neurology - Aventura Neurologic Associates | Aventura33180 | NCT07284784 | Map |
| FL | Arrow Clinical Trials | Daytona Beach32117 | NCT07284784 | Map |
| FL | Accel Clinical Sites-Georgia LLC dba Accel Research Sites-Lake Oconee CRU | DeLand32720 | NCT07284784 | Map |
| FL | Renstar Medical Research | Ocala34470 | NCT07284784 | Map |
| FL | University of South Florida (USF) - University of South Florida College of Medicine - Parkinson's Di | Tampa33613 | NCT07284784 | Map |
| FL | Conquest Research | Winter Park32789 | NCT07284784 | Map |
| GA | iResearch Atlanta | Decatur30030 | NCT07284784 | Map |
| IN | Josephson Wallack Munshower Neurology, P.C. | Indianapolis46256 | NCT07284784 | Map |
| KS | University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D | Kansas City66160 | NCT07284784 | Map |
| MI | Quest Research Institute | Farmington Hills48334 | NCT07284784 | Map |
| NC | Duke Department of Neurosurgery | Durham27710 | NCT07284784 | Map |
| OH | The Ohio State University Wexner Medical Center | Columbus43210 | NCT07284784 | Map |
| OK | The Movement Disorder Clinic of Oklahoma | Tulsa74136 | NCT07284784 | Map |
| PA | Abington Neurology | Willow Grove19090 | NCT07284784 | Map |
| TN | Neurology Clinic, P.C. | Cordova38018 | NCT07284784 | Map |
| TN | Veracity Neuroscience LLC | Memphis38157 | NCT07284784 | Map |
| TX | Central Texas Neurology | Round Rock78681 | NCT07284784 | Map |
| VA | University of Virginia Health System (UVAHS) - Adult Neurology Clinic | Charlottesville22903 | NCT07284784 | Map |
| WA | Inland Northwest Research | Spokane99202 | NCT07284784 | Map |
| WI | Medical College of Wisconsin | Milwaukee53226 | NCT07284784 | Map |
buntanetap/posiphen clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | completed | Total |
|---|---|---|---|---|
| P2/P3 | 1 | 1 | 2 | |
| P3 | 1 | 1 | 2 |
Recruiting buntanetap/posiphen clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07284784 | A Study of Buntanetap in Participants With PD | P2/P3 | Parkinson's Disease (PD) | 500 | Jan 2026 |
buntanetap/posiphen clinical trials by indication
Parkinson's Disease (PD) (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07284784 | — | P2/P3 | recruiting | A Study of Buntanetap in Participants With PD |
Early Alzheimers Disease (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06709014 | — | P3 | active not recruiting | A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD |
Alzheimer Disease (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05686044 | — | P2/P3 | completed | A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD |
Parkinson's Disease, Idiopathic (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05357989 | — | P3 | completed | A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD |
All buntanetap/posiphen trials (4)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07284784 | A Study of Buntanetap in Participants With PD | P2/P3 | recruiting | 500 | Annovis Bio Inc. | Jan 2026 | |
| NCT06709014 | A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD | P3 | active not recruiting | 760 | Annovis Bio Inc. | Feb 2025 | |
| NCT05686044 | A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD | P2/P3 | completed | 351 | Annovis Bio Inc. | Apr 2023 | |
| NCT05357989 | A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD | P3 | completed | 523 | Annovis Bio Inc. | Aug 2022 |
buntanetap/posiphen clinical trials: frequently asked questions
- How many buntanetap/posiphen clinical trials are there?
- 4 buntanetap/posiphen clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 2 are marked completed.
- Are buntanetap/posiphen clinical trials recruiting in 2026?
- Yes — 1 buntanetap/posiphen trial is actively recruiting in 2026, with 25 U.S. sites across 19 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is buntanetap/posiphen being studied for?
- buntanetap/posiphen is being studied for Alzheimer Disease, Deep Brain Stimulation, Early Alzheimers Disease, Parkinson's Disease (PD), Parkinson's Disease, Idiopathic. The trials are grouped by indication on this page.
- What phase is buntanetap/posiphen in?
- buntanetap/posiphen clinical trials span 2 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors buntanetap/posiphen clinical trials?
- The lead sponsor across the most buntanetap/posiphen trials is Annovis Bio Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming buntanetap/posiphenas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: